Pfizer-BioNTech COVID-19 Vaccine supplied in a multiple dose vial with a purple cap is authorized for use to provide: • a 2-dose primary series to individuals 12 years of age and older; and • a third primary series dose to individuals 12 years of age and older with certain kind...
Today, the U.S. Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age. The authorization was based on the FDA's thorough and transparent...
The FDA has determined that the known and potential benefits of a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for children 5 through 11 years of age at least five months after completing a primary series outweigh its known and potential risks, and that a booster dose can hel...
LOS ANGELES, May 19 (Xinhua) -- The U.S. Centers for Disease Control and Prevention (CDC) on Thursday recommended a booster dose of the Pfizer-BioNTech COVID-19 vaccine for children aged 5 to 11. The CDC recommends children in this age group receive a booster shot five months after the...
A booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 16 years of age and older. The vaccine is also authorized for eligible i...
Pfizer is expected to request authorization for a fourth COVID-19 vaccine dose for seniors in a move to provide extra protection to the over-65 population that has been hit hardest by the pandemic.
TheAlabama Department of Public Health(ADPH)announced new Covid-19 vaccine recommendationsfrom the Centers for Disease Control and Prevention (CDC). The CDC has authorized the use of the Pfizer-BioNTech vaccine as a single booster dose in individuals 12 through 15 years of age. ...
During anAxios COVID-19 vaccine eventon May 19, both the CEO of Moderna and the CEO of Pfizer said that depending on the research being done on the efficacy and longevity of the vaccines, a booster shot could be needed between either eight to 12 months after the recipient’s initial ...
Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers Data indicate that a third dose of BNT
(FDA)authorized the emergency use of Pfizer’s COVID-19 vaccine, which was co-developed with Germany-based BioNTech SE (BNTX), for use by children 5 through 11 years of age. The FDA said that the vaccine for this age group is to be administered as a two-dose primary series, three ...